WORLD US COVID-19 vaccine efficacy drops after Delta variant becomes predominant: CDC

WORLD

US COVID-19 vaccine efficacy drops after Delta variant becomes predominant: CDC

Xinhua

21:42, August 26, 2021

WASHINGTON, Aug. 26 (Xinhua) -- US vaccine effectiveness against COVID-19 has declined from 91 percent to 66 percent amid the predominance of the highly contagious COVID-19 Delta variant in the country, according to a study by the Centers for Disease Control and Prevention (CDC).

File photo: CFP

"While we did see a reduction in the protection of the COVID-19 vaccine against the Delta variant, it's still two-thirds reduction of risk," Ashley Fowlkes, lead author of the study published on Tuesday, told CNN.

Vaccines are still "very powerful," especially when it comes to more severe outcomes, Fowlkes, an epidemiologist for CDC COVID-19 Emergency Response, told the Atlanta-headquartered television channel on Tuesday.

"But we are also looking towards continuing to use masks for a little bit longer," the expert noted.

The current study does not cover disease severity, however. Instead, the new paper is the latest chapter in an ongoing study that has been following "health care personnel, first responders, and other essential and frontline workers" who receive weekly PCR tests in eight locations across six US states.

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue